WSB Gravimetric Blenders
Published

Arxada and Troy to Join in Creating a Comprehensive Offering in Microbial Control

The combined company’s technology synergies will accelerate innovation and technical solutions for customers.  

Share

A new company that will have an expanded portfolio in microbial control additives for plastics, paints and coatings is planned by Switzerland-based Arxada and Troy Corp. The two companies have entered into an agreement to join and create a new company that will broaden the sales support, technical development and manufacturing footprint, with complementary capabilities in North and South America, Europe, Asia and Oceania. Technology synergies are expected to accelerate innovation and technical solutions for customers. The partners will work to close the transaction as soon as possible, subject to obtaining customary approvals.

Arxada and Troy to combine microbial control businesses
Photo Credit: Arxada

This agreement represents the first strategic deal by global specialty chemicals business Arxada--formerly known as Lonza Specialty Ingredients or LSI and owned by private equity funds Bain Capital and Cinven, since the purchase from Lonza Group AG in July 2021. As part of the deal structure, Troy’s owners will invest in the combined company.

The partnership reportedly is a logical next step in Arxada’s strategy to strengthen its offering and enhance the capabilities of its Microbial Control Solutions (MCS) business. Troy is a global leader in the field of industrial preservation with broad expertise in paints and coatings, wood protection and preservation, home and personal care, plastics and textiles, energy and metal working fluids. The combination will create a comprehensive and innovative offering in microbial control, enabling the delivery of new solutions and value-added services to customers.

Troy Corp. lab for antimicrobial additives
Photo Credit: Troy Corp.

Arxada will benefit from Troy’s technical expertise, trusted customer relationships and broad portfolio of performance products as well as a long history of innovation, including the invention of 3-iodo propynyl butyl carbamate (IPBC), which Arxada does not currently manufacture. In addition, the proposed transaction will enhance Arxada’s commercial presence across the globe and add several production sites in important locations including Newark,N.J., Horhausen, Germany, Moerdijk, Netherlands and Kabinburi, Thailand. This extensive manufacturing footprint will allow the combined entity to better serve customer needs and strengthen its position as a trusted partner of choice in microbial control.

Related Content

Masters of Blending
WSB Gravimetric Blenders